PTGDR2 antagonists patented by Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery Feb. 5, 2018
Tetra Bio-Pharma cleared to begin phase III trial of PPP-001 in patients with terminal cancer Feb. 5, 2018